Mirage News·3 min read·hard
Opioid Treatment Adoption Uneven Across U.S
✦AI Summary
A Rutgers Health study reveals a tenfold increase in the use of long-acting injectable buprenorphine for opioid use disorder between 2021 and 2024. While adoption is growing, researchers noted significant regional disparities in how the medication is being utilized across the U.S.
There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, according to a Rutgers Health study.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in